Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 21Neoplasms 3Prostate Adenocarcinoma 2Urogenital Neoplasms 1Prostatic Diseases 1PSA Level Greater Than Two 1Neoplasms, Glandular and Epithelial 1Genital Neoplasms, Male 1Carcinoma 1Adenocarcinoma 1

Interventions

napabucasin 2Irinotecan 2Gemcitabine 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2sipuleucel-T 1pralsetinib 1pembrolizumab 1luprolide acetate gel depot 1catumaxomab 1Vaccines 1Papillomavirus Vaccines 1Papanicolaou Test 1Leuprolide 1Leucovorin 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Human Papillomavirus DNA Tests 1Fluorouracil 1Colposcopy 1Cisplatin 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neoplasms, Glandular and Epithelial × luprolide acetate gel depot × Clear all
NCT01431391 2017-05-30

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Dendreon

Phase 2 Completed
68 enrolled 11 charts
Genitourinary

Adenocarcinoma, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡